184 related articles for article (PubMed ID: 7493395)
21. Inhibition of interleukin-1 (alpha and beta), interleukin-2 secretion and surface expression of interleukin-2 receptor (IL-2R) by a novel cytokine interleukin-1 receptor antagonist (IL-1ra).
Conti P; Panara MR; Porrini AM; Gambi D; Barbacane RC; Reale M; Bongrazio M; Dempsey RA
Scand J Immunol; 1992 Jul; 36(1):27-33. PubMed ID: 1535451
[TBL] [Abstract][Full Text] [Related]
22. Detection of soluble interleukin-2 receptor and interleukin-10 in the serum of patients with aggressive non-Hodgkin's lymphoma. Identification of a subset at high risk of treatment failure.
Stasi R; Zinzani L; Galieni P; Lauta VM; Damasio E; Dispensa E; Dammacco F; Tura S; Papa G
Cancer; 1994 Sep; 74(6):1792-800. PubMed ID: 8082082
[TBL] [Abstract][Full Text] [Related]
23. Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis.
Famularo G; Procopio A; Giacomelli R; Danese C; Sacchetti S; Perego MA; Santoni A; Tonietti G
Clin Exp Immunol; 1990 Sep; 81(3):368-72. PubMed ID: 2397608
[TBL] [Abstract][Full Text] [Related]
24. The significance of serum soluble IL-2 receptor as a marker for active visceral leishmaniasis in Sicilian patients.
Vitale G; Reina G; Mansueto S; Malta R; Gambino G; Mocciaro C; D'Agostino R; Dieli M; Cillari E
Clin Exp Immunol; 1992 Nov; 90(2):219-22. PubMed ID: 1424277
[TBL] [Abstract][Full Text] [Related]
25. Effect of luteinizing hormone alpha-subunit on IL-2 and sIL-2R in vitro secretions from human peripheral blood mononuclear cells.
Komorowski J; Gradowski G; Stepień H
Cytobios; 1997; 89(356):31-7. PubMed ID: 9297814
[TBL] [Abstract][Full Text] [Related]
26. Soluble interleukin-2 receptor levels in cerebrospinal fluid of patients with acute lymphocytic leukemia or with non-Hodgkin's lymphoma.
Chang CS; Liu HW; Lin SF; Chen TP
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 May; 22(2):132-7. PubMed ID: 2605973
[TBL] [Abstract][Full Text] [Related]
27. Serum soluble interleukin-2 receptor levels are associated with clinical disease status and histopathological grade in non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
Barak V; Ginzburg M; Kalickman I; Polliack A
Leuk Lymphoma; 1992 Aug; 7(5-6):431-8. PubMed ID: 1493444
[TBL] [Abstract][Full Text] [Related]
28. The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back.
Berghella AM; Pellegrini P; Del Beato T; Marini M; Tomei E; Adorno D; Casciani CU
Cancer Immunol Immunother; 1998 Jan; 45(5):241-9. PubMed ID: 9439647
[TBL] [Abstract][Full Text] [Related]
29. Detection of soluble IL-2 receptor in the serum and bone marrow of patients with minimal residual hematological malignancies: induction under therapy with IL-2.
Kandefer-Szerszeń M; Legieć W; Dmoszyńska A; Rzeski W
Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):443-8. PubMed ID: 9437500
[TBL] [Abstract][Full Text] [Related]
30. High cytokine expression and reduced ovarian reserve in patients with Hodgkin lymphoma or non-Hodgkin lymphoma.
Paradisi R; Vicenti R; Macciocca M; Seracchioli R; Rossi S; Fabbri R
Fertil Steril; 2016 Oct; 106(5):1176-1182. PubMed ID: 27430206
[TBL] [Abstract][Full Text] [Related]
31. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
[TBL] [Abstract][Full Text] [Related]
32. Measurement of Soluble Interleukin 2 Receptor in Sera of Adult Patients with Hematological or Solid Malignancies.
Delforge A; Bernier M; Bosmans E; Massy M; Bron D; Heyligen H; Raus J; Mendes Da Costa P; Stryckmans P
Leuk Lymphoma; 1991; 3(5-6):385-93. PubMed ID: 27467429
[TBL] [Abstract][Full Text] [Related]
33. The role of tumor-associated macrophages on serum soluble IL-2R levels in B-cell lymphomas.
Sakai A; Yoshida N
J Clin Exp Hematop; 2014; 54(1):49-57. PubMed ID: 24942946
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of serum soluble interleukin-2 receptor level in non-Hodgkin's lymphoma: a single center study in Japan.
Kono N; Kanda Y; Yamamoto R; Chizuka A; Suguro M; Hamaki T; Arai C; Matsuyama T; Takezako N; Miwa A; Togawa A
Leuk Lymphoma; 2000 Mar; 37(1-2):151-6. PubMed ID: 10721779
[TBL] [Abstract][Full Text] [Related]
35. Soluble interleukin-2 receptor and soluble CD8 antigen in active rheumatoid arthritis.
Zielinski CC; Pesau B; Müller C
Clin Immunol Immunopathol; 1990 Oct; 57(1):74-82. PubMed ID: 2118434
[TBL] [Abstract][Full Text] [Related]
36. Effects of thyrotropin, follicle stimulating hormone and luteinizing hormone on sIL-2R in vitro secretion from human peripheral blood mononuclear cells.
Komorowski J; Jankiewicz J; Stepień H
Cytobios; 1998; 93(372):43-8. PubMed ID: 9721635
[TBL] [Abstract][Full Text] [Related]
37. Influence of low dose rIL-2 treatment on endogenous cytokine production, expression of surface IL-2R and the level of soluble IL-2R in patients with minimal residual disease.
Dmoszyńska A; Kandefer-Szerszeń M; Roliński J; Legieć W; Kamińska T
Leuk Lymphoma; 1999 Oct; 35(3-4):355-66. PubMed ID: 10706460
[TBL] [Abstract][Full Text] [Related]
38. Aggressive non-Hodgkin's lymphoma: concomitant evaluation of interleukin-2, soluble interleukin-2 receptor, interleukin-4, interleukin-6, interleukin-10 and correlation with outcome.
Fabre-Guillevin E; Tabrizi R; Coulon V; Monnereau A; Eghbali H; Soubeyran I; Soubeyran P
Leuk Lymphoma; 2006 Apr; 47(4):603-11. PubMed ID: 16690518
[TBL] [Abstract][Full Text] [Related]
39. Serum level of soluble interleukin-2 receptor correlates with CD25 expression in patients with T lymphoblastic lymphoma.
Toji T; Takata K; Sato Y; Miyata-Takata T; Hayashi E; Habara T; Maeda Y; Tanimoto M; Yoshino T
J Clin Pathol; 2015 Aug; 68(8):622-7. PubMed ID: 25935549
[TBL] [Abstract][Full Text] [Related]
40. [Effects of smoking on interleukin-2 and its receptor system in human peripheral blood].
Jiao L; Gan D; Fang Y
Wei Sheng Yan Jiu; 1998 Nov; 27(6):385-8. PubMed ID: 11939024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
